Enzolytics Inc logo

Enzolytics Inc

$ 0.03 -0.0015 (-5.08%) 12:51 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 63.88M
Enterprise V:
$ 72.55M
Volume:
2.31M
Avg Vol (2M):
5.70M
Volume:
2.31M
Market Cap $:
63.88M
PE Ratio:
At Loss
Avg Vol (2-Month):
5.70M
Enterprise Value $:
72.55M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies and an artificial intelligence (AI) platform for heath care developments. The Company has clinically tested anti HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.

Financial Strength

Name Current Vs Industry Vs History
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 18.86
9-Day RSI 21.16
14-Day RSI 23.26
6-1 Month Momentum % -36.06
12-1 Month Momentum % -71.23

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

ENZC's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ENZC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.046
EPS (TTM) ($) -170.268
Beta 0.85
Volatility % 84.53
14-Day RSI 23.26
14-Day ATR ($) 0.0047
20-Day SMA ($) 0.038535
12-1 Month Momentum % -71.23
52-Week Range ($) 0.027 - 0.2032
Shares Outstanding (Mil) 2,438.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Enzolytics Inc Filings

Document Form Filing Date
No Filing Data

Enzolytics Inc Analysis

Share your research

Headlines

See More
No news.